Judy Y. Wu

Family Medicine
13677 W McDowell Rd
Goodyear, AZ 85395

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: January 05, 2013
Showing 1-1 of 1

Last Updated: 09/26/2026